Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
5.90
-0.24 (-3.91%)
At close: May 17, 2024, 4:00 PM
6.06
+0.16 (2.71%)
After-hours: May 17, 2024, 7:31 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $382.89 million as of May 17, 2024. Its market cap has decreased by -48.03% in one year.
Market Cap
382.89M
Enterprise Value
142.66M
1-Year Change
-48.03%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has decreased from $406.10M to $382.89M, a decrease of -5.72%. That is a compound annual growth rate of -1.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 397.10M | 2.50% |
May 15, 2024 | 387.40M | - |
May 14, 2024 | 387.40M | 1.71% |
May 13, 2024 | 380.90M | 5.95% |
May 10, 2024 | 359.50M | -5.12% |
May 9, 2024 | 378.90M | -3.12% |
May 8, 2024 | 391.10M | 5.02% |
May 7, 2024 | 372.40M | -0.51% |
May 6, 2024 | 374.30M | 6.43% |
May 3, 2024 | 351.70M | 2.84% |
May 2, 2024 | 342.00M | 4.14% |
May 1, 2024 | 328.40M | 0.58% |
Apr 30, 2024 | 326.50M | -0.97% |
Apr 29, 2024 | 329.70M | 3.88% |
Apr 26, 2024 | 317.40M | 5.80% |
Apr 25, 2024 | 300.00M | -2.31% |
Apr 24, 2024 | 307.10M | 1.29% |
Apr 23, 2024 | 303.20M | -2.70% |
Apr 22, 2024 | 311.60M | 5.70% |
Apr 19, 2024 | 294.80M | -0.67% |
Apr 18, 2024 | 296.80M | 1.12% |
Apr 17, 2024 | 293.50M | -2.78% |
Apr 16, 2024 | 301.90M | -7.70% |
Apr 15, 2024 | 327.10M | -1.56% |
Apr 12, 2024 | 332.30M | -1.54% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Organogenesis Holdings | 393.74M |
Esperion Therapeutics | 391.96M |
Tourmaline Bio | 391.11M |
Shattuck Labs | 388.02M |
Nevro | 387.86M |
Anika Therapeutics | 386.73M |
Verrica Pharmaceuticals | 386.02M |
Contineum Therapeutics | 384.75M |